G Protein Coupled Receptor Pathway
- G proteins, also known as guanine nucleotide-binding proteins,
involved in transmitting signals and function as molecular
switches.
- G protein-coupled receptors (GPCRs), also known as
seven-transmembrane domain receptors, serpentine receptor, and G
protein-linked receptors (GPLR),
- It constitute a large protein family of receptors that sense
molecules outside the cell and activate inside signal transduction
pathways and ultimately, cellular responses.
- GPCRs are responsible for every aspect of human biology from
vision, taste, sense of smell, sympathetic and parasympathetic
nervous functions, metabolism, and immune regulation to
reproduction.
- 45% of all pharmaceutical drugs are known to target GPCRs
Structure of GPCR can be divided into three
parts:
- 1.The extra-cellular region, consisting of the N terminus and
three extracellular loops (ECL1–ECL3);
- The TM region, consisting of seven a-helices(TM1– TM7)
- The intracellular region, consisting of three intra- cellular
loops (ICL1–ICL3), an intracellular amphipathic helix (H8), and the
C terminus .
G protein complexes are Made up
of
- 23 alpha
(α)
- 7 beta (β)
- 12 gamma (γ) subunits.
- Beta and gamma subunits can form a stable dimeric complex
referred to as the beta-gamma complex
- The extracellular region modulates ligand access; the TM region
forms the structural core, binds ligands and transduces this
information to the intracellular region through conformational
changes, and the intracellular region interfaces with cytosolic
signalling proteins
- The α subunits fall into four families (Gs, Gi, Gq, and G12/13)
which are responsible for coupling GPCRs to relatively distinct
effectors.
MECHANISM
- When an agonist binds to a GPCR, there is a conformational
change in the receptor that is transmitted from the ligand-binding
pocket to the second and third intracellular loops of the receptor
which couple to the G protein heterotrimer.
- GPCR results in a conformation change in the receptor that is
transmitted to the bound Gα subunit .
- This conformational change causes the α subunit to exchange its
bound GDP for GTP.
- Binding of GTP activates the α subunit and causes it to release
both the βγ dimer and the receptor, and active signaling molecules,
both the GTP-bound α subunit and the βγ heterodimer become and
active signaling molecules .
- The interaction of the agonist-bound GPCR with the G protein is
transient; following activation of one G protein, the receptor is
freed to interact with other G proteins.
Principal signal transduction pathways involving the G
protein–coupled receptors:
- cAMP signal pathway
- the phosphatidylinositol signal pathway
Depending on the nature of the subunit, the active, GTP-bound
form binds to and regulates effectors such as adenylyl cyclase (via
Gs ) or phospholipase C (via Gq ).
The subunit can regulate many effectors including ion channels
and enzymes such as PI3-K(phosphoinositide 3- kinase).
The G protein remains active until the GTP bound to the subunit
is hydrolyzed to GDP.
The α subunit has a slow
intrinsic rate of GTP hydrolysis that is modulated by a family of
proteins termed regulators of G protein signaling
(RGSs).
The RGS proteins greatly accelerate the hydrolysis of GTP and
are potentially attractive drug targets.
Once the GDP bound to the α
subunit is hydrolyzed to GDP, the βγ subunit and receptor recombine
to form the inactive receptor-G protein heterotrimer basal complex
that can be reactivated by another ligand-binding
event
The main targets for G-proteins, through which GPCRs
control different aspects of cell function are
- adenylyl cyclase, the enzyme responsible for cAMP
formation
- phospholipase C, the enzyme responsible for inositol phosphate
and diacylglycerol (DAG) formation
- ion channels, particularly calcium and potassium channels
- Rho A/Rho kinase, a system that controls the activity of many
signalling pathways controlling cell growth and proliferation,
smooth muscle contraction
The Adenylyl cyclase/cAMP
signal pathway
- cAMP is a nucleotide
- Synthesized within the cell from ATP by membrane-bound,
adenylyl cyclase
- Produced continuously
- Inactivated by hydrolysis to 5´-AMP, by the
Phosphodiesterases
- Involved in: Energy metabolism Cell division and cell
differentiation Ion transport, ion channels Contractile proteins in
smooth muscle
Nucleotide Exchange Factors (Gefs)
- Integrate extracellular signals from membrane
receptors to produce cytoskeletal changes
- This pathway provides an additional effector system for cAMP
signaling and drug action that can act independently or
cooperatively with PKA
- Activation of diverse signaling pathways, regulate :
Phagocytosis Progression through the cell cycle Cell adhesion Gene
expression Apoptosis
Phosphodiesterases - Hydrolyze the cyclic
3',5'-phosphodiester bond in cAMP and cGMP
- Drug targets for : Asthma Cardiovascular diseases such as heart
failure Atherosclerotic coronary and peripheral arterial disease
Neurological disorders
The Phospholipase C/
inositol phosphate system
- PIP2 is the substrate for a membrane-bound enzyme,
phospholipase Cβ (PLCβ),
- Which splits it into DAG and inositol (1,4,5) trisphosphate
(IP3)
- Both function as second messengers - IP3 receptor- a
ligand-gated calcium channel present on the membrane of the
endoplasmic reticulum
- Diacylglycerol and protein kinase C
- DAG, unlike the inositol phosphates, is highly lipophilic and
remains within the membrane
- Binds to a specific site on the PKC molecule, which migrates
from the cytosol to the cell membrane in the presence of DAG,
thereby becoming activated
- Kinases in general play a central role in signal transduction,
and control many different aspects of cell function
- The Rho/Rho kinase system
- Activated by certain GPCRs (and also by non-GPCR mechanisms),
which couple to G-proteins of the G12/13 type
- Rho-GDP, the resting form, is inactive
- When GDP-GTP exchange occurs, Rho is activated - In turn
activates Rho kinase
- involved in Smooth muscle contraction and proliferation,
angiogenesis and synaptic remodeling
- Important in the pathogenesis of pulmonary hypertension